A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series

被引：24
|
作者：
Vaz, RJ [1 ]
Nayeem, A [1 ]
Santone, K [1 ]
Chandrasena, G [1 ]
Gavai, AV [1 ]
机构：
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 17期
关键词：
CYP2D6; 3D-QSAR; aryloxypropanolamines;
D O I：
10.1016/j.bmcl.2005.06.007
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A comparative molecular similarity index analysis (CoMSiA) has been performed for cytochrome P450 2D6 inhibition on a series of aryloxypropatiolamines to determine the factors contributing to this activity. The model is in agreement with a CYP2D6 homology model constructed on the basis of the mammalian CYP2C5 crystal structure. The energy minimized conformations were generated using the systematic search methodology in Sybyl 6.7. The model not only elucidated the relationship between structure and biological activity but, more importantly, provided useful strategies to modulate CYP2D6 affinity in the aryloxypropanolamine series. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3816 / 3820
页数：5
相关论文
共 50 条
  • [41] DOSE DEPENDENT CYP2D6 INHIBITION BY BUPROPION AND LEVOMEPROMAZINE
    Haslemo, T.
    Arnestad, M.
    Molden, E.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 6 - 7
  • [42] In vivo inhibition of CYP2C19 but not CYP2D6 by fluvoxamine
    Xu, ZH
    Xie, HG
    Zhou, HH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (04) : 518 - 521
  • [43] Frequencies of Three CYP2D6 Nonfunctional Alleles (CYP2D6☆3, ☆4, and ☆6) Within an Iranian Population (Mazandaran)
    Hashemi-Soteh, Seyed Mohammad Bagher
    Sarzare, Fatemeh
    Merat, Fatemeh
    Salehifar, Ebrahim
    Shiran, Mohammad-Reza
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2011, 15 (11) : 821 - 825
  • [44] Forecasting CYP2D6 and CYP3A4 Risk with a Global/Local Fusion Model of CYP450 Inhibition
    Ewing, Todd
    Feher, Miklos
    MOLECULAR INFORMATICS, 2010, 29 (1-2) : 127 - 141
  • [45] CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene
    Skierka, Jennifer M.
    Walker, Denise L.
    Peterson, Sandra E.
    O'Kane, Dennis J.
    Black, John Logan, III
    PHARMACOGENOMICS, 2012, 13 (08) : 951 - 954
  • [46] 3D-QSAR illusions
    Arthur M. Doweyko
    Journal of Computer-Aided Molecular Design, 2004, 18 : 587 - 596
  • [47] CYP2D6 and CYP3A influence tamoxifen and endoxifen
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (05) : 524 - 525
  • [48] Rethinking 3D-QSAR
    Richard D. Cramer
    Journal of Computer-Aided Molecular Design, 2011, 25 : 197 - 201
  • [49] 3D-QSAR illusions
    Doweyko, AM
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2004, 18 (7-9) : 587 - 596
  • [50] Rethinking 3D-QSAR
    Cramer, Richard D.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2011, 25 (03) : 197 - 201
12345